Novartis Confident About Further Growth For 'Big Two'

New Indications On Track For Cosentyx And Entresto

 
• By Kevin Grogan
Vas Narasimhan
Vas Narasimhan says Cosenty and Entresto will hit 2025 sales targets • Source: Novartis

More from Clinical Trials

More from R&D